Between 2026 and 2034, companion animal healthcare looks set for one of its strongest growth runs. Over that period, the Isoxazoline Market is expected to advance at a 14.45% CAGR, moving from US$ 6.25 Billion in 2025 to US$ 21.06 Billion by 2034. Flea and tick protection sits firmly at the centre of that story.
What Is Driving the Market?
Pest control innovation is the first driver....
Global Veterinary Drugs Market Poised to Reach USD 60.85 Billion by 2032, Growing at 5.5% CAGR as Companion Animal Humanization and Sustainable Livestock Biosecurity Drive Pharmaceutical Innovation
The global animal health sector is undergoing a profound structural evolution, driven by the dual imperatives of food security for an expanding human population and the elevation of companion...
